These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
809 related articles for article (PubMed ID: 19556829)
1. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells. Rajah TT; Du N; Drews N; Cohn R Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829 [TBL] [Abstract][Full Text] [Related]
2. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation. Power KA; Thompson LU Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916 [TBL] [Abstract][Full Text] [Related]
3. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells. Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518 [TBL] [Abstract][Full Text] [Related]
5. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531 [TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. Kostelac D; Rechkemmer G; Briviba K J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520 [TBL] [Abstract][Full Text] [Related]
7. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Seo HS; DeNardo DG; Jacquot Y; Laïos I; Vidal DS; Zambrana CR; Leclercq G; Brown PH Breast Cancer Res Treat; 2006 Sep; 99(2):121-34. PubMed ID: 16541309 [TBL] [Abstract][Full Text] [Related]
8. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. McCarty MF Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288 [TBL] [Abstract][Full Text] [Related]
9. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. van der Woude H; Ter Veld MG; Jacobs N; van der Saag PT; Murk AJ; Rietjens IM Mol Nutr Food Res; 2005 Aug; 49(8):763-71. PubMed ID: 15937998 [TBL] [Abstract][Full Text] [Related]
10. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio. Sotoca AM; Ratman D; van der Saag P; Ström A; Gustafsson JA; Vervoort J; Rietjens IM; Murk AJ J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):171-8. PubMed ID: 18955141 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERalpha- and ERbeta-mRNA and protein expresion. Staar S; Richter DU; Makovitzky J; Briese V; Bergemann C Anticancer Res; 2005; 25(3A):1713-8. PubMed ID: 16033089 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications. Hartman J; Ström A; Gustafsson JA Steroids; 2009 Aug; 74(8):635-41. PubMed ID: 19463683 [TBL] [Abstract][Full Text] [Related]
13. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells. Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Helguero LA; Faulds MH; Gustafsson JA; Haldosén LA Oncogene; 2005 Oct; 24(44):6605-16. PubMed ID: 16007178 [TBL] [Abstract][Full Text] [Related]
15. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. Liu ZJ; Zhu BT J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420 [TBL] [Abstract][Full Text] [Related]
16. Additive effects of trastuzumab and genistein on human breast cancer cells. Lattrich C; Lubig J; Springwald A; Goerse R; Ortmann O; Treeck O Anticancer Drugs; 2011 Mar; 22(3):253-61. PubMed ID: 21160418 [TBL] [Abstract][Full Text] [Related]
17. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells. Cappelletti V; Miodini P; Di Fronzo G; Daidone MG Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234 [TBL] [Abstract][Full Text] [Related]
18. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk. Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631 [TBL] [Abstract][Full Text] [Related]
19. Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Dip R; Lenz S; Antignac JP; Le Bizec B; Gmuender H; Naegeli H Endocr Relat Cancer; 2008 Mar; 15(1):161-73. PubMed ID: 18310284 [TBL] [Abstract][Full Text] [Related]
20. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]